ISMAIL AHMAD SHALABY MD PHD
Prescription History 1881761815
Ophthalmology in Baltimore, MD
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for ISMAIL AHMAD SHALABY MD PHD, an active Ophthalmology specialist practicing in Baltimore, MD. Our medical registry currently tracks 22 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,163 documented patient claims. Among these therapy options, the most frequently utilized medication is Ofloxacin, which accounts for 151 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other MD PrescribersVs. MD Avg |
|---|---|---|---|
| Ofloxacin | 151 | $14.42▼ below MD avg | ▲ More than typical |
About Ofloxacin: This medication is used to treat eye infections. Show more ▾ Ofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION. In 2023, this provider wrote 151 Medicare prescriptions for Ofloxacin, about 3.2 times the volume of the typical Maryland prescriber of this medication (47). Medicare paid an average of $14.42 per fill, versus $21.19 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 155.5 30-Day Fills standardized to 30-day supplies 3,859 Days of Medication total across all patients in 2023 | |||
| Latanoprost | 150 | $29.18 | ▲ More than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 150 Medicare prescriptions for Latanoprost, about 1.3 times the volume of the typical Maryland prescriber of this medication (119). Medicare paid an average of $29.18 per fill, versus $21.84 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 378 30-Day Fills standardized to 30-day supplies 11,248 Days of Medication total across all patients in 2023 | |||
| Lotemax SmLoteprednol Etabonate | 89 | $250.71 | ▲ More than typical |
About Lotemax Sm: This medication is used to temporarily relieve seasonal allergy symptoms of the eyes such as swelling, redness, and itching. Show more ▾ Loteprednol belongs to a class of drugs known as corticosteroids. An androstadiene derivative corticosteroid that is used as an ANTI-ALLERGIC AGENT for the treatment of inflammatory and allergic eye conditions. In 2023, this provider wrote 89 Medicare prescriptions for Lotemax Sm, about 1.9 times the volume of the typical Maryland prescriber of this medication (48). Medicare paid an average of $250.71 per fill, versus $238.57 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 90.3 30-Day Fills standardized to 30-day supplies 2,248 Days of Medication total across all patients in 2023 | |||
| LumiganBimatoprost | 87 | $697.60 | ▲ More than typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 87 Medicare prescriptions for Lumigan, about 1.5 times the volume of the typical Maryland prescriber of this medication (58). Medicare paid an average of $697.60 per fill, versus $563.04 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 210.8 30-Day Fills standardized to 30-day supplies 6,289 Days of Medication total across all patients in 2023 | |||
| ProlensaBromfenac Sodium | 87 | $365.37 | ▲ More than typical |
About Prolensa: This medication is used to treat swelling (inflammation) and pain in the eye after a certain type of eye surgery (cataract surgery). Show more ▾ Bromfenac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking the effects of certain natural substances (prostaglandins) that cause pain and inflammation. In 2023, this provider wrote 87 Medicare prescriptions for Prolensa, about 2.1 times the volume of the typical Maryland prescriber of this medication (42). Medicare paid an average of $365.37 per fill, versus $353.66 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 125.5 30-Day Fills standardized to 30-day supplies 3,694 Days of Medication total across all patients in 2023 | |||
| RestasisCyclosporine | 72 | $1,313.01 | ▲ More than typical |
About Restasis: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. In 2023, this provider wrote 72 Medicare prescriptions for Restasis, about 1.7 times the volume of the typical Maryland prescriber of this medication (42). Medicare paid an average of $1,313.01 per fill, versus $1,301.47 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 140 30-Day Fills standardized to 30-day supplies 4,200 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 69 | $25.60▼ below MD avg | ≈ Typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 69 Medicare prescriptions for Dorzolamide-Timolol, about 85% of the volume of the typical Maryland prescriber of this medication (81). Medicare paid an average of $25.60 per fill, versus $35.15 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 127.9 30-Day Fills standardized to 30-day supplies 3,834 Days of Medication total across all patients in 2023 | |||
| VyzultaLatanoprostene Bunod | 59 | $498.63▼ below MD avg | ▲ More than typical |
About Vyzulta: Latanoprostene bunod is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by controlling the flow of fluid within the eye to maintain a normal pressure. In 2023, this provider wrote 59 Medicare prescriptions for Vyzulta, about 2.3 times the volume of the typical Maryland prescriber of this medication (26). Medicare paid an average of $498.63 per fill, versus $539.04 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 98.3 30-Day Fills standardized to 30-day supplies 2,818 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate | 50 | $77.05 | ≈ Typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 50 Medicare prescriptions for Brimonidine Tartrate, about the same volume as the typical Maryland prescriber of this medication (55). Medicare paid an average of $77.05 per fill, versus $49.50 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 76.1 30-Day Fills standardized to 30-day supplies 2,194 Days of Medication total across all patients in 2023 | |||
| XiidraLifitegrast | 47 | $1,107.18▼ below MD avg | ▲ More than typical |
About Xiidra: This medication is used to treat dry eye disease. In 2023, this provider wrote 47 Medicare prescriptions for Xiidra, about 1.8 times the volume of the typical Maryland prescriber of this medication (26). Medicare paid an average of $1,107.18 per fill, versus $1,223.01 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 77.7 30-Day Fills standardized to 30-day supplies 2,330 Days of Medication total across all patients in 2023 | |||
| CombiganBrimonidine Tartrate/Timolol | 46 | $423.51▼ below MD avg | ≈ Typical |
About Combigan: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 46 Medicare prescriptions for Combigan, about the same volume as the typical Maryland prescriber of this medication (40). Medicare paid an average of $423.51 per fill, versus $453.20 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 75.6 30-Day Fills standardized to 30-day supplies 2,209 Days of Medication total across all patients in 2023 | |||
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 44 | $76.10▼ below MD avg | ▲ More than typical |
About Tobramycin-Dexamethasone: This medication is used to treat or prevent eye infections. Show more ▾ This medication contains two drugs. Tobramycin belongs to a class of drugs called aminoglycoside antibiotics. It works by stopping the growth of bacteria. Dexamethasone belongs to a class of drugs called corticosteroids. It works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A topical preparation of tobramycin and dexamethasone that is used for treating or preventing superficial bacterial infections of the eye. In 2023, this provider wrote 44 Medicare prescriptions for Tobramycin-Dexamethasone, about 1.5 times the volume of the typical Maryland prescriber of this medication (29). Medicare paid an average of $76.10 per fill, versus $82.03 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 48.2 30-Day Fills standardized to 30-day supplies 1,076 Days of Medication total across all patients in 2023 | |||
| Ketorolac Tromethamine | 36 | $23.99▼ below MD avg | ▼ Less than typical |
About Ketorolac Tromethamine: This medication is used to temporarily relieve itching eyes caused by seasonal allergies. Show more ▾ It is also used to prevent and treat eye swelling due to a certain type of eye surgery (cataract removal). Ketorolac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain natural substances in your body to reduce pain and swelling. A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is a non-steroidal anti-inflammatory agent used for analgesia for postoperative pain and inhibits cyclooxygenase activity. In 2023, this provider wrote 36 Medicare prescriptions for Ketorolac Tromethamine, about half the volume of the typical Maryland prescriber of this medication (72). Medicare paid an average of $23.99 per fill, versus $29.12 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 46.7 30-Day Fills standardized to 30-day supplies 1,303 Days of Medication total across all patients in 2023 | |||
| CequaCyclosporine | 31 | $782.07 | ≈ Typical |
About Cequa: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. In 2023, this provider wrote 31 Medicare prescriptions for Cequa, about the same volume as the typical Maryland prescriber of this medication (32). Medicare paid an average of $782.07 per fill, versus $726.49 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 43 30-Day Fills standardized to 30-day supplies 1,290 Days of Medication total across all patients in 2023 | |||
| Loteprednol Etabonate | 28 | $162.33▼ below MD avg | ▲ More than typical |
About Loteprednol Etabonate: This medication is used to temporarily relieve seasonal allergy symptoms of the eyes such as swelling, redness, and itching. Show more ▾ Loteprednol belongs to a class of drugs known as corticosteroids. An androstadiene derivative corticosteroid that is used as an ANTI-ALLERGIC AGENT for the treatment of inflammatory and allergic eye conditions. In 2023, this provider wrote 28 Medicare prescriptions for Loteprednol Etabonate, about 1.4 times the volume of the typical Maryland prescriber of this medication (20). Medicare paid an average of $162.33 per fill, versus $215.48 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 35.5 30-Day Fills standardized to 30-day supplies 960 Days of Medication total across all patients in 2023 | |||
| Timolol Maleate | 27 | $29.58▼ below MD avg | ≈ Typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2023, this provider wrote 27 Medicare prescriptions for Timolol Maleate, about 1.2 times the volume of the typical Maryland prescriber of this medication (23). Medicare paid an average of $29.58 per fill, versus $500.63 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 48.3 30-Day Fills standardized to 30-day supplies 1,420 Days of Medication total across all patients in 2023 | |||
| SimbrinzaBrinzolamide/Brimonidine Tart | 20 | $281.34▼ below MD avg | ≈ Typical |
About Simbrinza: This product contains two medications used to treat high pressure in the eye due to glaucoma (open-angle glaucoma-type) or a certain other eye disease (ocular hypertension). Show more ▾ Lowering high pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This product contains brinzolamide and brimonidine. These two medications work together to decrease the amount of fluid within the eye. Brinzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. Brimonidine belongs to a class of drugs known as alpha agonists. This product is not recommended for use in children younger than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. In 2023, this provider wrote 20 Medicare prescriptions for Simbrinza, about 80% of the volume of the typical Maryland prescriber of this medication (25). Medicare paid an average of $281.34 per fill, versus $309.23 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 33.4 30-Day Fills standardized to 30-day supplies 988 Days of Medication total across all patients in 2023 | |||
| Dorzolamide Hcl | 17 | $34.09 | ▼ Less than typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 17 Medicare prescriptions for Dorzolamide Hcl, about a third of the volume of the typical Maryland prescriber of this medication (43). Medicare paid an average of $34.09 per fill, versus $31.70 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 41.3 30-Day Fills standardized to 30-day supplies 1,240 Days of Medication total across all patients in 2023 | |||
| Travoprost | 17 | $253.51▼ below MD avg | ▼ Less than typical |
About Travoprost: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 17 Medicare prescriptions for Travoprost, about half the volume of the typical Maryland prescriber of this medication (32). Medicare paid an average of $253.51 per fill, versus $303.72 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 41.7 30-Day Fills standardized to 30-day supplies 1,250 Days of Medication total across all patients in 2023 | |||
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 13 | $11.73▼ below MD avg | ▼ Less than typical |
About Neomycin-Polymyxin-Dexameth: This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. Show more ▾ This product contains neomycin and polymyxin, antibiotics that work by stopping the growth of bacteria. It also contains dexamethasone, an anti-inflammatory corticosteroid that works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (such as infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. In 2023, this provider wrote 13 Medicare prescriptions for Neomycin-Polymyxin-Dexameth, about a third of the volume of the typical Maryland prescriber of this medication (38). Medicare paid an average of $11.73 per fill, versus $14.08 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 13.1 30-Day Fills standardized to 30-day supplies 215 Days of Medication total across all patients in 2023 | |||
| Bromfenac Sodium | 12 | $298.48 | ▼ Less than typical |
About Bromfenac Sodium: This medication is used to treat swelling (inflammation) and pain in the eye after a certain type of eye surgery (cataract surgery). Show more ▾ Bromfenac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking the effects of certain natural substances (prostaglandins) that cause pain and inflammation. In 2023, this provider wrote 12 Medicare prescriptions for Bromfenac Sodium, about a third of the volume of the typical Maryland prescriber of this medication (30). Medicare paid an average of $298.48 per fill, versus $195.70 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 18.5 30-Day Fills standardized to 30-day supplies 493 Days of Medication total across all patients in 2023 | |||
| ErythromycinErythromycin Base | 11 | $12.69▼ below MD avg | ▼ Less than typical |
About Erythromycin: Erythromycin is used to treat a wide variety of bacterial infections. Show more ▾ It may also be used to prevent certain bacterial infections. Erythromycin is known as a macrolide antibiotic. It works by stopping the growth of bacteria. This antibiotic treats or prevents only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. In 2023, this provider wrote 11 Medicare prescriptions for Erythromycin, about a third of the volume of the typical Maryland prescriber of this medication (35). Medicare paid an average of $12.69 per fill, versus $18.58 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 11 30-Day Fills standardized to 30-day supplies 218 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for ISMAIL AHMAD SHALABY MD PHD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Ophthalmology prescribing approach at this Baltimore, MD practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among MD prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
